Physician profile
John W Cory
NPI 1760474845
$2,623.78
in general payments reported to CMS, 2019-2025
19 companies · $90.89 in 2025
The $90.89 reported for 2025 was less than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $490 · 2020: $168 · 2021: $292 · 2022: $213 · 2023: $51.84 · 2024: $1,318 · 2025: $90.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $741 · Food and Beverage: $720.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $740.96 |
| Food and Beverage | $719.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,669.12 | 2020-2025 | Inbone, Prophecy, Prostep |
| Wright Medical Technology, INC. | $212.58 | 2019 | |
| Smith+Nephew, INC. | $120.90 | 2019-2024 | Evos, Evos Mini, Acticoat 4" X 4" |
| Bioventus LLC | $108.09 | 2021-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Sanara Medtech INC. | $77.36 | 2024 | Celleraterx |
| Depuy Synthes Sales INC. | $69.62 | 2019-2021 | |
| Orthofix Medical, INC. | $43.18 | 2019-2020 | |
| Medartis INC. | $41.15 | 2019 | |
| Forte Bio-Pharma LLC | $37.77 | 2019 | |
| Abbott Laboratories | $37.40 | 2019-2022 | |
| Celularity INC. | $33.00 | 2019 | |
| Kci USA, INC. | $30.10 | 2022 | |
| Osteomed LLC | $29.58 | 2021 | |
| Djo, LLC | $27.80 | 2019 | |
| Abbvie INC. | $24.21 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $18.74 | 2019 | |
| Zimmer Biomet Holdings, INC. | $18.36 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $13.62 | 2023 | Seglentis |
| Integra Lifesciences Corporation | $11.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Cory listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.